Hydroxyzine Tablets/Capsules Suppliers & Bulk Manufacturers
Available Forms: Tablets/Capsules
Available Strengths: 10 mg, 25 mg, 50 mg, 100 mg
Reference Brands: US: Vistaril®, , Atarax®; EU: Atarax®, Hydroxyzine Mylan®, Ucerax®
Category:
Antipsychotropic Drugs
Hydroxyzine acts by blocking H1 histamine receptors, reducing allergic symptoms like itching and rashes. It also exerts anxiolytic and sedative effects through CNS depression, making it useful for treating anxiety, tension, pruritus, and as a preoperative sedative. Tablets and capsules provide convenient oral dosing for adults.
Hydroxyzine Tablets/Capsules is available in Tablets/Capsules
and strengths such as 10 mg, 25 mg, 50 mg, 100 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Hydroxyzine Tablets/Capsules is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Hydroxyzine Tablets/Capsules can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Hydroxyzine tablets and capsules are FDA-approved in the USA for treating anxiety, tension, pruritus, and for sedation. Widely prescribed in both adults and children, labeling emphasizes dose adjustments, CNS effects, and contraindications in patients with prolonged QT interval. In the European Union, hydroxyzine is authorized under national procedures, not centralized, with restrictions in some countries due to cardiac safety concerns. EU regulations mandate clear warnings on QT prolongation, drug interactions, and age-based contraindications. Pharmacovigilance measures, including risk minimization plans, are strictly enforced. For sourcing and detailed product listings, visit Pharmatradz.com.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing